<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00612157</url>
  </required_header>
  <id_info>
    <org_study_id>WRAMC07-17022</org_study_id>
    <nct_id>NCT00612157</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)</brief_title>
  <acronym>CPAPASAP</acronym>
  <official_title>Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Effect of Eszoplicone on Initial Continuous Positive Airway Pressure (CPAP) Compliance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunovion</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Walter Reed Army Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of Eszopiclone in improving short and
      intermediate-term compliance with continuous positive airway pressure (CPAP) in patients
      newly diagnosed with obstructive sleep apnea (OSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CPAP is the treatment of choice for patients with OSA. However, patients are frequently
      intolerant of this therapy initially. After continued use, tolerance is achieved. However,
      this initial discomfort or intolerance frequently leads to a patient-initiated
      discontinuation of therapy. It has been shown that CPAP use at 1 month predicts use at 6
      months and 1 year. Patients who initially struggle with or are intolerant of CPAP frequently
      abandon therapy and are unlikely to use it long term. To prevent this, sleep physicians often
      prescribe short courses of sedatives to help improve initial tolerance and promote better
      compliance with therapy. However, the effectiveness of this practice has not been validated
      in a clinical trial. Compliance, in reference to this study is the willingness of the
      patients to follow the prescribed course of treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short term CPAP Compliance</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Intermediate CPAP Compliance</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Issue - Prostate Symptoms for men</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Issue - Erectile Dysfunction for men</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Issue - Sleepiness</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Issue - Fatigue</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Issue - Subjective Sleep Quality</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>OSA CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eszopiclone</intervention_name>
    <description>Eszopiclone 3mg orally at bedtime for 14 nights</description>
    <arm_group_label>OSA CPAP</arm_group_label>
    <other_name>Lunesta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo control</intervention_name>
    <description>Matching placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  Newly diagnosed with OSA who are prescribed CPAP therapy

        Exclusion Criteria:

          -  Patients &lt; 18 years old

          -  Patients over 65 years

          -  Pregnant women

          -  Patients with chronic liver disease

          -  Patients who abuse alcohol

          -  Patients taking narcotics or using sedative-hypnotic agents such as Ambien, Klonopin
             or Benadryl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher J Lettieri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Walter Reed Army Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed Army Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20307</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lettieri CJ, Eliasson AH, Andrada T, Khramtsov A, Raphaelson M, Kristo DA. Obstructive sleep apnea syndrome: are we missing an at-risk population? J Clin Sleep Med. 2005 Oct 15;1(4):381-5.</citation>
    <PMID>17564406</PMID>
  </reference>
  <reference>
    <citation>Quera-Salva MA, McCann C, Boudet J, Frisk M, Borderies P, Meyer P. Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers. Br J Clin Pharmacol. 1994 Jun;37(6):539-43.</citation>
    <PMID>7917771</PMID>
  </reference>
  <reference>
    <citation>Feinberg I, Maloney T, Campbell IG. Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res. 2000 Nov-Dec;34(6):423-38.</citation>
    <PMID>11165310</PMID>
  </reference>
  <reference>
    <citation>Blois R, Gaillard JM, Attali P, Coquelin JP. Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings. Clin Ther. 1993 Sep-Oct;15(5):797-809.</citation>
    <PMID>8269446</PMID>
  </reference>
  <reference>
    <citation>Ballester E, Badia JR, Hern√°ndez L, Carrasco E, de Pablo J, Fornas C, Rodriguez-Roisin R, Montserrat JM. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999 Feb;159(2):495-501. Erratum in: Am J Respir Crit Care Med 1999 May;159(5 Pt 1):1688.</citation>
    <PMID>9927363</PMID>
  </reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2008</study_first_submitted>
  <study_first_submitted_qc>February 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2008</study_first_posted>
  <last_update_submitted>February 25, 2009</last_update_submitted>
  <last_update_submitted_qc>February 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christopher J. Lettieri, MD / Pulmonary, Critical Care &amp; Sleep Medicine</name_title>
    <organization>Walter Reed Army Medical Center</organization>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <keyword>CPAP Compliance</keyword>
  <keyword>Non-benzodiazepine hypnotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eszopiclone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

